This clinical trial focuses on understanding immune system responses in patients with autoimmune diseases, specifically Systemic Sclerosis, Systemic Lupus Erythematosus, and Rheumatoid Arthritis. These conditions occur when the body’s immune system mistakenly attacks its own tissues. The study will use a Tetanus Toxoid vaccine, which is commonly used to protect against tetanus infection, to examine how the immune system responds in people with these conditions compared to healthy individuals.
The study aims to examine how specific immune cells called B cells respond to the tetanus vaccine in people with autoimmune diseases. Participants will receive a single booster shot of the tetanus vaccine as a suspension for injection into the muscle. The amount given will be 0.5 milliliters, which is a standard vaccine dose.
During the study, researchers will collect blood samples at different times to observe how the immune system responds to the vaccine. They will look at special immune cells and proteins in the blood before and after vaccination. This will help them understand the differences between how the immune system works in people with autoimmune diseases compared to people without these conditions.



The Netherlands